News

Direct Identification of MRSA Strains within 18 Hours

12 Sept 2010
Sarah Sarah
Marketing / Sales

Product news

BioMérieux launches a new version of chromID™ MRSA chromogenic medium for the detection of methicillin resistant Staphylococcus aureus (MRSA), providing a cost effective solution for rapid routine screening.

This ready-to-use medium for the culture, isolation and identification of MRSA offers direct identification of MRSA strains within 18 hours, and sensitivity is increased by a further 7% when flocked swabs are used for transportation providing a good synergy with the PREVI Isola automated plate streaker.

The characteristic colours of the colonies – pale blue-green at 18 hours incubation and blue¬ green to dark blue at 24 hours incubation – make results easy to read, and the medium has been validated for use with PREVI™ Isola, VITEK®2 and API® platforms. With a maximum read time of 24 hours, compared to 48 hours for the previous version, the new version chromID agar has the potential to increase throughput significantly.

Daniel White, product manager, bioMérieux, said: “Compared to traditional culture media, chromogenic media offer the laboratory an easier method of identifying bacteria through colour differentiation. The intensity and specificity of the colours produced make rapid, easy identification of bacterial colonies possible; this new chromID MRSA chromogenic medium will be a great advantage to our customers releasing time and space within the laboratory while at the same time allowing earlier reporting of negatives to facilitate faster clinical decisions.”

Links

Tags

Point-of-CarePoint-of-Care Testing (POCT) or Near Patient Testing (NPT) products are available for urine, blood and other clinical chemistry analyses. POCT includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing (PT / INR), rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.
Direct Identification of MRSA Strains within 18 Hours